With the COVID pandemic sadly still raging on, the world has perhaps never been more alive to the destructive power of infectious diseases – and the vital medicines we need to help keep them in check.
Now with members in 135 countries around the world, the Society continues to play a pivotal role to help ensure new drugs are developed, while making sure we use the ones we already have are used responsibly and protected for future generations. We know that better education can help prevent disease, develop more effective practice and influence international policy, and with that in mind we are now providing more opportunities for open-access learning and events than ever before. Our internationally renowned publications, The Journal of Antimicrobial Chemotherapy, and JAC-AMR, continue to publish cutting edge research and education from around the word, as well as review articles offering in-depth discussion on matters of topical concern.
Meanwhile, our new health initiative, Stop Superbugs, seeks to bridge the gap between professionals in the UK and their colleagues in low- and middle-income countries, helping ensure we take a global approach to AMR – an issue the WHO has declared one of the top 10 global public health threats facing humanity.
Though we are all living through difficult times, here at BSAC we believe the future is bright. Through hard work, education and dedication, we know we can build a safer world for all. Through a series of publications, blogs and activities we will celebrate the achievements of founders and members to date, and explore the vanguard issues across research, surveillance, big data, clinical practice, education and more that will shape the infection landscape going forward.
We thank our members and colleagues around the globe and stand shoulder to shoulder with you, ready for the challenges the next fifty years may bring.
CEO of the British Society for Antimicrobial Chemotherapy